Pharma company acquires startup Oculeve for $125m (USD), including a novel nasal device for dry eye disease

Appraisal body calls for more information from drug company before issuing final guidance to NHS on dry eye treatment

New market report predicts growth will be driven by the launch of a number of new drugs and fixed-dose combinations

US study shows that standard 2g/day dose of metformin could potentially reduce the risk of open-angle glaucoma in diabetic patients by more than 20%

Early findings from phase II trials show positive results in treating optic neuritis, which may affect half of patients with multiple sclerosis

Evidence has emerged that Novartis may have launched a sustained campaign to block the off label use of cancer drug Avastin over its licensed treatment, Lucentis

US biohackers have reportedly boosted the dim-light vision of a test subject enabling him to better identify objects in a darkened environment

Clinical commissioning group (CCG) has cancelled plans to switch to Avastin for AMD patients, despite potential NHS savings of more than £100m a year

The heads of 120 CCGs have renewed calls to remove the barriers to practitioners using the cheaper drug for patients with wet AMD